158 related articles for article (PubMed ID: 29687929)
1. A tale of two clones: Caldesmon staining in the differentiation of cutaneous spindle cell neoplasms.
Beck EM; Bauman TM; Rosman IS
J Cutan Pathol; 2018 Aug; 45(8):581-587. PubMed ID: 29687929
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of smooth muscle myosin, smooth muscle actin, h-caldesmon, and calponin in the diagnosis of myofibroblastic and smooth muscle lesions of skin and soft tissue.
Perez-Montiel MD; Plaza JA; Dominguez-Malagon H; Suster S
Am J Dermatopathol; 2006 Apr; 28(2):105-11. PubMed ID: 16625070
[TBL] [Abstract][Full Text] [Related]
3. Calponin and h-caldesmon expression in atypical fibroxanthoma and superficial leiomyosarcoma.
Sakamoto A; Oda Y; Yamamoto H; Oshiro Y; Miyajima K; Itakura E; Tamiya S; Honda Y; Ishihara A; Iwamoto Y; Tsuneyoshi M
Virchows Arch; 2002 Apr; 440(4):404-9. PubMed ID: 11956822
[TBL] [Abstract][Full Text] [Related]
4. h-Caldesmon as a specific marker of smooth muscle cell differentiation in some soft tissue tumors of the skin.
D'Addario SF; Morgan M; Talley L; Smoller BR
J Cutan Pathol; 2002 Aug; 29(7):426-9. PubMed ID: 12139638
[TBL] [Abstract][Full Text] [Related]
5. P75 nerve growth factor receptor as a useful marker to distinguish spindle cell melanoma from other spindle cell neoplasms of sun-damaged skin.
Sigal AC; Keenan M; Lazova R
Am J Dermatopathol; 2012 Apr; 34(2):145-50. PubMed ID: 22207443
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical distinction of cutaneous spindle cell carcinoma.
Morgan MB; Purohit C; Anglin TR
Am J Dermatopathol; 2008 Jun; 30(3):228-32. PubMed ID: 18496422
[TBL] [Abstract][Full Text] [Related]
7. Specific but variable expression of h-caldesmon in leiomyosarcomas: an immunohistochemical reassessment of a novel myogenic marker.
Hisaoka M; Wei-Qi S; Jian W; Morio T; Hashimoto H
Appl Immunohistochem Mol Morphol; 2001 Dec; 9(4):302-8. PubMed ID: 11759055
[TBL] [Abstract][Full Text] [Related]
8. h-Caldesmon expression effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors.
Nucci MR; O'Connell JT; Huettner PC; Cviko A; Sun D; Quade BJ
Am J Surg Pathol; 2001 Apr; 25(4):455-63. PubMed ID: 11257619
[TBL] [Abstract][Full Text] [Related]
9. [Pleomorphic and dedifferentiated leiomyosarcoma: a clinicopathologic analysis].
Sun M; Liu JG; Weng QY; Yu L; Wang J
Zhonghua Bing Li Xue Za Zhi; 2018 Feb; 47(2):87-93. PubMed ID: 29429158
[No Abstract] [Full Text] [Related]
10. Is anti-h-caldesmon useful for distinguishing smooth muscle and myofibroblastic tumors? An immunohistochemical study.
Ceballos KM; Nielsen GP; Selig MK; O'Connell JX
Am J Clin Pathol; 2000 Nov; 114(5):746-53. PubMed ID: 11068549
[TBL] [Abstract][Full Text] [Related]
11. h-caldesmon immunoreactivity in atypical fibroxanthoma: implications for the differential diagnosis.
Martinez-Ciarpaglini C; Agustà J; Alvarez E; Hueso L; Terrádez L; Monteagudo C
Pathology; 2018 Apr; 50(3):358-361. PubMed ID: 29490873
[No Abstract] [Full Text] [Related]
12. In regard to "A tale of two clones: Caldesmon staining in the differentiation of cutaneous spindle-cell neoplasms".
Martinez-Ciarpaglini C; Monteagudo C
J Cutan Pathol; 2018 Nov; 45(11):869-870. PubMed ID: 30054907
[No Abstract] [Full Text] [Related]
13. Pleomorphic and dedifferentiated leiomyosarcoma: clinicopathologic and immunohistochemical study of 41 cases.
Nicolas MM; Tamboli P; Gomez JA; Czerniak BA
Hum Pathol; 2010 May; 41(5):663-71. PubMed ID: 20004935
[TBL] [Abstract][Full Text] [Related]
14. Best practices in diagnostic immunohistochemistry: pleomorphic cutaneous spindle cell tumors.
Folpe AL; Cooper K
Arch Pathol Lab Med; 2007 Oct; 131(10):1517-24. PubMed ID: 17922587
[TBL] [Abstract][Full Text] [Related]
15. Spindle Cell Atypical Fibroxanthoma: Myofibroblastic Differentiation Represents a Diagnostic Pitfall in This Variant of AFX.
Harding-Jackson N; Sangueza M; Mackinnon A; Suster S; Plaza JA
Am J Dermatopathol; 2015 Jul; 37(7):509-14; quiz 515-6. PubMed ID: 26098709
[TBL] [Abstract][Full Text] [Related]
16. p63 is a useful marker for cutaneous spindle cell squamous cell carcinoma.
Dotto JE; Glusac EJ
J Cutan Pathol; 2006 Jun; 33(6):413-7. PubMed ID: 16776716
[TBL] [Abstract][Full Text] [Related]
17. The role of CD10 in distinguishing atypical fibroxanthoma from sarcomatoid (spindle cell) squamous cell carcinoma.
Wieland CN; Dyck R; Weenig RH; Comfere NI
J Cutan Pathol; 2011 Nov; 38(11):884-8. PubMed ID: 21883368
[TBL] [Abstract][Full Text] [Related]
18. IFITM1, CD10, SMA, and h-caldesmon as a helpful combination in differential diagnosis between endometrial stromal tumor and cellular leiomyoma.
Zhao W; Cui M; Zhang R; Shen X; Xiong X; Ji X; Tao L; Jia W; Pang L; Sun Z; Wang C; Zou H
BMC Cancer; 2021 Sep; 21(1):1047. PubMed ID: 34556086
[TBL] [Abstract][Full Text] [Related]
19. Spindle cell neoplasm of skin: diagnostic dilemma.
Jain M; Singh S; Agarwal K
Indian J Pathol Microbiol; 2007 Oct; 50(4):814-6. PubMed ID: 18306566
[TBL] [Abstract][Full Text] [Related]
20. h-Caldesmon, a novel smooth muscle-specific antibody, distinguishes between cellular leiomyoma and endometrial stromal sarcoma.
Rush DS; Tan J; Baergen RN; Soslow RA
Am J Surg Pathol; 2001 Feb; 25(2):253-8. PubMed ID: 11176075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]